Cargando…

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19

Lung alveolar type-II (AT-II) cells produce pulmonary surfactant (PS), consisting of proteins and lipids. The lipids in PS are primarily responsible for reducing the air-fluid surface tension inside the alveoli of the lungs and to prevent atelectasis. The proteins are of two types: hydrophilic and h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shengguang, Li, Zhen, Wang, Xinyu, Zhang, Shiming, Gao, Peng, Shi, Zuorong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276044/ https://www.ncbi.nlm.nih.gov/pubmed/34267664 http://dx.doi.org/10.3389/fphar.2021.698905

Ejemplares similares

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Qingfei Litan Decoction Against Acute Lung Injury/Acute Respiratory Distress Syndrome: The Potential Roles of Anti-Inflammatory and Anti-Oxidative Effects
por: Diao, Yirui, et al.
Publicado: (2022)

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

Surfactant alteration and replacement in acute respiratory distress syndrome
por: Günther, Andreas, et al.
Publicado: (2001)

Effect of different ventilation methods combined with pulmonary surfactant on neonatal acute respiratory distress syndrome
por: Qing, Qing, et al.
Publicado: (2023)

Role of Neuromuscular Blocking Agents in Acute Respiratory Distress Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials
por: Wei, Xue-biao, et al.
Publicado: (2020)

Profound Effect of Pulmonary Surfactant on the Treatment of Preterm Infants with Respiratory Distress Syndrome
por: Liu, Lin, et al.
Publicado: (2022)

Exogenous pulmonary surfactant for acute respiratory distress syndrome in adults: A systematic review and meta-analysis
por: ZHANG, LI-NA, et al.
Publicado: (2013)

Network analysis-based strategy to investigate the protective effect of cepharanthine on rat acute respiratory distress syndrome
por: Chen, Chen, et al.
Publicado: (2022)

Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
por: Chiang, Chih-Chao, et al.
Publicado: (2020)

STC3141 improves acute lung injury through neutralizing circulating histone in rat with experimentally-induced acute respiratory distress syndrome
por: Ge, Yangyang, et al.
Publicado: (2023)

Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?
por: Koumbourlis, Anastassios C., et al.
Publicado: (2020)

History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
por: Bae, Chong-Woo, et al.
Publicado: (2019)

Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis
por: Davidson, Warren J, et al.
Publicado: (2006)

Pulmonary surfactant function in patients with acute lung injury/acute respiratory distress syndrome treated by mechanical ventilation
por: Miller, E, et al.
Publicado: (2005)

Elucidation of the Mechanism of Action of Ginseng Against Acute Lung Injury/Acute Respiratory Distress Syndrome by a Network Pharmacology-Based Strategy
por: Ding, Qi, et al.
Publicado: (2021)

The effect of high-frequency oscillatory ventilator combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome
por: Wang, Tie-Yan, et al.
Publicado: (2022)

Efficacy of pulmonary surfactant combined with high-dose ambroxol hydrochloride in the treatment of neonatal respiratory distress syndrome
por: Xiang, Jiajun, et al.
Publicado: (2019)

Effects of metformin on acute respiratory distress syndrome in preclinical studies: a systematic review and meta-analysis
por: Wang, Liu, et al.
Publicado: (2023)

The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome
por: Cesta, Maria Candida, et al.
Publicado: (2022)

Continuous positive pressure ventilation combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome
por: Miao, Jing, et al.
Publicado: (2020)

Dry powder nebulization of a recombinant surfactant protein C-based surfactant for treatment of acute respiratory distress syndrome
por: Ruppert, C, et al.
Publicado: (2007)

Aspirin Attenuates Hyperoxia-Induced Acute Respiratory Distress Syndrome (ARDS) by Suppressing Pulmonary Inflammation via the NF-κB Signaling Pathway
por: Tung, Yu-Tang, et al.
Publicado: (2022)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Exogenous surfactant therapy for acute respiratory distress in infancy
por: Moreno, M., et al.
Publicado: (1996)

Surfactant Therapy for Respiratory Distress Syndrome in High- and Ultra-High-Altitude Settings
por: Duan, Xudong, et al.
Publicado: (2022)

Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration
por: Schmidt, Reinhold, et al.
Publicado: (2007)

Efficacy study of pulmonary surfactant combined with assisted ventilation for acute respiratory distress syndrome management of term neonates
por: Liu, Jinfeng, et al.
Publicado: (2017)

Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future
por: Amigoni, Angela, et al.
Publicado: (2017)

Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia
por: Putz, G., et al.
Publicado: (1996)

The Cholinergic Drug Pyridostigmine Alleviates Inflammation During LPS-Induced Acute Respiratory Distress Syndrome
por: Bricher Choque, Pamela Nithzi, et al.
Publicado: (2021)

Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury
por: Cattel, Francesco, et al.
Publicado: (2021)

The Controversy About the Effects of Different Doses of Corticosteroid Treatment on Clinical Outcomes for Acute Respiratory Distress Syndrome Patients: An Observational Study
por: Yang, Jia-Wei, et al.
Publicado: (2021)

Alveolar surfactant and adult respiratory distress syndrome: Pathogenetic role and therapeutic prospects
por: Seeger, W., et al.
Publicado: (1993)

Comparative Effectiveness of Midazolam, Propofol, and Dexmedetomidine in Patients With or at Risk for Acute Respiratory Distress Syndrome: A Propensity Score-Matched Cohort Study
por: Hu, An-Min, et al.
Publicado: (2021)

Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
por: Nagarkatti, Prakash, et al.
Publicado: (2020)

The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways
por: Sultan, Muthanna, et al.
Publicado: (2021)

Alleviation of Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats by Yiqi Huayu Jiedu Decoction: A Tandem Mass Tag-Based Proteomics Study
por: Luo, Chang-yong, et al.
Publicado: (2020)

Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome
por: Dushianthan, Ahilanandan, et al.
Publicado: (2014)

Breath-Synchronized Nebulized Surfactant in a Porcine Model of Acute Respiratory Distress Syndrome
por: DiBlasi, Robert M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gb9err5nph3ckdcajvl1ngmpnd